The global weight loss drug boom The last few years have witnessed a dramatic transformation in the perception and uptake of GLP-1based therapies
This hormone is also responsible for enhancing insulin sensitivity and regulating blood sugar levels ultimately leading to improved metabolic health and weight control
Additionally, native GLP-1 increases endothelial function and vasodilation in both diabetic and non-diabetic patients, regardless of alterations in insulin sensitivity
Shared Nordic Trends Across Denmark, Sweden, and Norway: Endocrinologists (hormone doctors), obesity specialists, and private weight clinics play a significant role in prescribing GLP-1 medicines Doctors encourage using these medicines together with healthy lifestyle changes, not as the only solution There have been supply shortages, especially for Wegovy, as more people seek these treatments
They go beyond just suggesting workout routines